chrisvoncsefalvay/vaers-outcomes huggingface dataset:
20 hours after shot, I developed arm pain, excessive lethargy/need to sleep most of the day, abdominal pain, nausea, muscle aches, and at 30 hours after vaccination a core temperature of 103.5 degrees. Fever broke 42 hours after vaccination. Feeling back to normal at 68 hours.
First two days, typical injection site soreness; third day my left shoulder joint had a tendonitis feel to it and it has progressively worsened such that range of motion is limited and certain movements very painful
Horrible headache, severe body aches, nausea, shortness of breath for 30 hours
Received PPV23 (SC) and TIV (IM) into left arm 10-21-98.  The patient called the office on 10-23-08 to report that her left arm  was red, hot, swollen with  pain and pressure from the elbow to the arm pit.  She relayed that the site was better on the 23rd than the 22nd.  A status call on 10-24-08 indicated that she had inproved since the 23rd and that she did not report that she was  nauseated with the other symptoms also.
p/vax pt devel fever of 100 & broke out in hives on arms & face & front & back of torso;mom states hives were huge;taken to MD;
Mother called 07/15 to report that child had adverse reaction. Call returned on 07/16 and mother stated that child had rash on back and diarrhea for three days starting the same day vaccines were administered.
This spontaneous report as received from a physician refers to a 17 years old female patient who on a unspecified date was vaccinated with the first dose of GARDASIL (lot # and dose of administration were not provided). No other co-suspects were reported. No concomitant medications were reported. On an unknown date, at the site of injection, the patient developed site of injection developed redness and site of an area that was rock-hard; this area was six to seven centimeters in diameter. The patient was under the care of the physician. At the time of the report, these adverse events lasted for a week and then resolved (on an unspecified date). Additional information  has been requested.
Never had anything so painful as this arm; has so much pain in this arm in the muscle; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Never had anything so painful as this arm) and MYALGIA (has so much pain in this arm in the muscle) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Never had anything so painful as this arm) and MYALGIA (has so much pain in this arm in the muscle). At the time of the report, PAIN IN EXTREMITY (Never had anything so painful as this arm) and MYALGIA (has so much pain in this arm in the muscle) outcome was unknown.            Reporter did not allow further contact
Pt recvd a series of 3 Engerix-B vax 8OCT90, 12NOV90, 8MAY91 & was a poss non-responder;
Extreme body and joint aches; joint aches; extreme fatigue/ very tired; cold sweats; This is a spontaneous report from a contactable consumer (patient).  A 47-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 23Feb2021 09:00 (Batch/Lot number was not reported), age at vaccination of 43-years-old, as single dose, for covid-19 immunisation.  Medical history included hypertension from an unknown date and unknown if ongoing.  The patient previously took nitric oxide and experienced hypersensitivity, received BNT162B2 dose 1 administered in Arm Left on 03Feb2021 01:00 PM (Batch/Lot number was not reported) for covid-19 immunisation.  Concomitant medications included metoprolol (METOPROLOL) taken for an unspecified indication, start and stop date were not reported; simvastatin (SIMVASTATIN) taken for an unspecified indication, start and stop date were not reported; bupropion hydrochloride (WELLBUTRIN) taken for an unspecified indication, start and stop date were not reported.  The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced extreme body and joint aches, extreme fatigue, cold sweats and was very tired, all on 24Feb2021. No treatments were given for the events. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient recovered from the events on an unspecified date.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
unbearable itching and a rash over my whole upper body, it has never completely gotten better. its in my head ,face, arms,back,chest. right now its worst than its ever been i have been to several Drs and no one know nothing about what is going on,But I am miserable, and I have never had anything like this until i took the shots. ms
This spontaneous report as received from a 73 year old female patient refers to herself. The patient's medical history included pneumonia. The patient had no drug allergies. Concomitant therapies included losartan (manufacturer unknown), carvedilol, aspirin (manufacturer unknown), furosemide (manufacturer unknown), potassium chloride (KLOR-CON), spironolactone and atorvastatin. On 02-FEB-2017, the patient was vaccinated with PNEUMOVAX 23 (dose, route and lot # not reported) for prevention of pneumonia. "About two weeks" after the vaccination, on approximately 16-FEB-2017, the patient developed bronchitis. Because the patient had taken an over the counter medication guaifenesin (MUCINEX), the patient recovered from the bronchitis on an unspecified date in 2017. On unspecified dates after recovering from bronchitis in approximately 2017, the patient felt like she "couldn't breath", had "chest pains that felt like heart failure", "loss of appetite", "woke up from hunger pains", and "had been sleeping only 3-4 hours each night". The patient saw her family physician for the adverse experiences; however, the physician "did not help (her) symptoms". On 14-AUG-2017, the patient developed swollen legs. The patient's cardiologist recommended that the patient had an echocardiogram performed. On 30-AUG-2017, the echocardiogram was performed and it showed that the patient had "edema" (the onset date of "edema" was unknown, estimated as in approximately 2017). Except bronchitis, the outcome of other events was reported as not recovered. Causality assessment was not provided. Upon internal review, chest pains that felt like heart failure and "edema" on echocardiogram were considered to be medically significant.
UNKNOWN VACCINE INFORMATION INCLUDING DATES AND LOT NUMBERS. PATIENT HOSPITALIZED WITH DIAGNOSIS OF BREAKTHROUGH COVID
Has patch on her back by scapula that is bright red, blotchy. Also red swollen at injection site on left thigh. Mom does not think it looks infected, no blisters, No sign of bite. Not peeling. Was the size of mom's thumb, but now the size of her hand. On 05/11/2016 mother called back and pt has fluid filled blisters all over her body. States siblings have gotten chicken pox from vaccine and have had them multiple times, so strong family history.
Pain at site of vaccination. Red itchy, swollen entire arm till elbow for 2 days. Then go away in 2 days.
Left foot has been numb ever since got home from vaccine. Can bend toes, walk, and move on foot, but the whole top is numb to touch.; This is a spontaneous report from a non-contactable consumer, the patient. A 21-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732, Expiration date: an unknown date in Jul2021) via an unspecified route of administration in the left arm on 11Apr2021 at 15:00(at the age of 21-years-old) as a single dose for COVID-19 immunisation. The medical history included sulphonamide allergy. Concomitant medications included clindamycin (CLINDAMICINA) and benzyl peroxide (MANUFACTURER UNKNOWN) started on unknown dates and for unspecified indications. The patient previously took amoxicillin (MANUFACTURER UNKNOWN) and augmentin (MANUFACTURER UNKNOWN) on an unknown date and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Apr2021, reportedly the patient's left foot has been numb ever since got home from vaccine. She can bend toes, walk, and move on foot, but the whole top was numb to touch. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of this event. The clinical outcome of the event left foot has been numb ever since got home from vaccine. she can bend toes, walk, and move on foot, but the whole top is numb to touch was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Patient received vaccines at the Mobile Site. Patient stated after receiving the vaccines that she felt hot. Patient skin pale in color. Patient mother stated patient had not eaten. Patient mother feed patient Jello and a apple. Patient given water to drink.  Patient color return to appropriate color for race. Patient denied feeling hot. Patient Temperature- 98.4, Blood Pressure-100/62, SATO2-98 %, Respirations-16, and Pulse-91. Offered to call emergency services for patient. Patient mother and patient refuse emergency services. Patient monitored for 30 minutes. Patient and patient mother denies any complaints prior to leaving post vaccination area.
Case number PHHY2011US31279 is an initial spontaneous report received from a nurse on 12 Apr 2011 with a follow up report from nurse on 03 May 2011. This report concerns an 11-year-old girl. She was vaccinated with MENVEO (batch number: 024011) 0.5 ml, intramuscularly on 21 Feb 2011. She concomitantly received BOOSTRIX (batch number: AC5B048AC) on 21 Feb 2011. She received only the Men CYW-135 liquid conjugate vaccine component of the vaccine and did not receive the Men A lyophilized conjugate component. No adverse event was reported following this drug administration error. Non significant follow up report was received on 12 Apr 2011: No new information was provided. Follow up information received on 03 May 2011: Patient demographics, vaccination details and concomitant vaccine updated.
pt received vaccine on 10/27/20 and reported to pharmacist 12/11/20 that she had experienced a rapid heart beat 12 hours after being vaccinated.  she wanted reaction to be reported due to concern of upcoming COVID vaccine and if there would be a shared reaction.  pt has not reacted to any vaccine prior.  Pt is seeing doctor tomorrow 12-12-20 and will report to dr at that time
Rapid Heart Rate Chest pains Pains on side where shot was given Left arm pain  Left neck pain
dizziness; palpitations; lightheadedness; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 33 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 07Jan2021 (Lot number: ek9231) at the age of 33 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "covid-19" (unspecified if ongoing), notes: covid prior vaccination. There were no concomitant medications. The following information was reported: DIZZINESS (hospitalization, disability) with onset 07Jan2021, outcome "not recovered", described as "dizziness"; PALPITATIONS (hospitalization, disability) with onset 07Jan2021, outcome "not recovered", described as "palpitations"; DIZZINESS (hospitalization, disability) with onset 07Jan2021, outcome "not recovered", described as "lightheadedness". The patient was hospitalized for dizziness, palpitations, dizziness (hospitalization duration: 3 day(s)). The events "dizziness", "palpitations" and "lightheadedness" were evaluated at the physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (17Nov2021) negative, notes: Nasal Swab. Therapeutic measures were taken as a result of dizziness, palpitations, dizziness including IV fluids, meds. AE resulted in: [Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization, Disability or permanent damage]. No other medications the patient received within 2 weeks of vaccination. No other vaccines within 4 weeks prior to the COVID vaccine.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of Dizziness, Palpitations cannot be totally excluded.   The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
pt recvd vax;8sep95 in er w/ redness,swelling,tender area right upper arm extending over elbow w/ 2-3 blistered areas;no axillary lymphadenitis;dph given & instructed to apply cold packs;dx pos rxn to MMR vs Cellulitis;
rash on side of body,  treating with cortisone cream at this time / skin feels as if its burning. and prickly,  on arms and face. like a sunburn  but I have not been in the sun.
Constant headache. Headache located mostly in lower right of head. Have had it 24/7 since shot.  Headache medication will relieve for a few hours, but it comes right back.
Covid monitoring documentation. PT admitted 1/4/21 documented to have positive covid. PT received Moderna 1/29/21 Lot 028L20A for dose 1. Dose 2 was Moderna given on 2/26/21 Lot 028L20A.
This spontaneous report was received from a certified medical assistant, referring to an unspecified number of patients of unknown age and gender. Information regarding concurrent conditions and medical history was not provided. On an unspecified date, unspecified number of PEDVAXHIB vaccines were exposed to 58 degrees F for 94 hours. After that, on unspecified dates, the patients were vaccinated with lot number: L012835 (expiration date: 11-MAR-2018) (dose and route were not provided). No adverse events were reported. The medical assistant stated that the vaccines were not previous exposed to temperature excursion. Information was recorded from a data logger. This is one of two reports received from the same source. Additional information has been requested.
Intermittent Vertigo; This case was reported by a nurse via call center representative and described the occurrence of vertigo in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 27th January 2020, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 months after receiving Shingrix, the patient experienced vertigo. On an unknown date, the outcome of the vertigo was not recovered/not resolved.   It was unknown if the reporter considered the vertigo to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported, however it could be 59 or 60 years. The patient started to experience vertigo intermittently.
Woke at 1a with fever, 101°. Nausea. Extreme weakness, dry mouth.  Lasted 3 hours.
Developed non-radiating substernal chest heaviness. No associated symptoms. Felt the symptoms 4-5 days after my booster moderna vaccine but transient, occurred ~2 times. Then 10 days after my dose the chest discomfort recurred and day 11 became persistent prompting an emergency department visit for the discomfort on day 12 post vaccine. Workup negative but felt could be mild myocarditis, possibly vaccine related.
This case was reported by a pharmacist via call center representative and described the occurrence of erythema in a female patient who received SHINGRIX (batch number 5544H, expiry date 15th May 2021) for prophylaxis. On 19th February 2019, the patient received SHINGRIX (intramuscular) .5 ml. On an unknown date, 1 day after receiving SHINGRIX, the patient experienced erythema, skin warm and pain. The patient was treated with Ice Pack (No Medication). On an unknown date, the outcome of the erythema and pain were recovering/resolving and the outcome of the skin warm was recovered/resolved. It was unknown if the reporter considered the erythema, skin warm and pain to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient received SHINGRIX on the right deltoid. The pharmacist stated that they gave a SHINGRIX vaccine to the patient and down below the injection there was a red warm area, like it hurt her. They did put an ice pack on it, which took away the heat feeling. The reporter clarified that it was an inch or two from the injection site and it started to develop the next day. The reporter then called the patient a couple days after and she said it was getting a lot better. It was not a rash or infection. The patient declined to provide date of birth. Information as provided by caller.
COVID-19 Post Vaccine #2 Vasovagal reaction. EMS notified due to patients history of anxiety and increase in RR, patient stated she feels "shaky". Patient stated she feels better with legs elevated. Patient lowered to the ground, legs elevated and moved to the litter. VS taken and EMS notified.
slight fever, chills, sweating, slight nausea, listlessness. Took OTC ibuprofen.  Felt better by 10:30 the next day and thought it was going away but chills and sweating returned last night.
Patient states painful and sore arm with a knot at site of injection; limited range of motion. Patient states occurred shortly after injection.  Went to doctor on 11/20/15, at which time doctor told patient to take ibuprofen and use hot compress to alleviate pain.  Patient called me on 12/3/15 stating the above and that it does not seem to be getting better; she will call with update.  I called doctor on 2/15/16 to see if any follow-up had been done by patient.  Spoke to person who states patient called still complaining of pain and limited range of motion due to vaccination.  Dr. has referred patient to Physical Medicine Specialist at this time.  Dr's office will inform us of any outcome.
flu symptoms; headache; body aches; slight fever; chills; extreme fatigue.; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old male patient received his second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: unknown) via an unspecified route of administration in the left arm on 23Mar2021 at 12:30 (at the age of 50-years-old) for COVID-19 immunisation. The patient medical history and concomitant medications was not reported and known allergies were reported as no. The other vaccination within four weeks prior to the COVID-19 vaccine was reported as no. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient received his first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: unknown) via an unspecified route of administration in the left arm on 02Mar2021 at 12:30 (at the age of 50-years-old) for COVID-19 immunisation. Facility where the COVID-19 vaccine was administered was at the hospital. On 24Mar2021at 08:00, the patient experienced flu symptoms, headache, body aches, slight fever, chills and extreme fatigue. No therapeutic measures were taken for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events experienced flu symptoms, headache, body aches, slight fever, chills and extreme fatigue was recovering at the time of this report.  Information about lot/batch number cannot be obtained. No further information is expected.
Headache, Fever, NauseaVomiting, Cough no wheezing Narrative:
Information has been received on 08-AUG-2017 from a lawyer and a female patient of unknown age regarding a case in litigation. The patient's concurrent conditions, medical history and concomitant medications were not reported. On an unknown date, the patient was inoculated with ZOSTAVAX, (lot number and expiration not reported) subcutaneous as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 28-MAY-2016, the patient was treated by a physician in a physician's office for the onset of a severe vesicular rash accompanied by weakened immune symptoms, which was diagnosed as abdominal herpes zoster, or shingles with post-herpetic neuralgia. Post-herpetic neuralgia is a chronic condition of nerve pain and damage secondary to shingles infections. The patient has been prescribed gabapentin and NEURONTIN for management of her painful symptoms. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
This spontaneous report was received from a nurse refers to unspecified patients of unknown gender and age. Information regarding patients' medical history, concurrent condition, drug reactions/allergies and concomitant therapy was not provided. On unspecified dates, the patients were vaccinated with an improperly stored dose of GARDASIL 9 (Lot # L013429, expiry date: 29-JUL-2017; Lot # L017407, expiry date: 15-AUG-2017). The temperature excursion details for vaccine were as follows: temperature 27.4 F, time frame 37.36 hours. The nurse reported a temperature excursion for the following products: GARDASIL 9 (Lot # L013429, expiry date: 29-JUL-2017; Lot # L017407, expiry date: 15-AUG-2017), M-M-R II (Lot # L012480, expiry date: 10-APR-2017) and PEDVAXHIB (lot # L030872, expiry date: 11-JUN-2018), however only GARDASIL 9 dose was administered. No adverse effect was reported. This is one of two reports received from the same reporter. Additional information has been requested.
Wrong dose. Patient was given pfizer 0.3ml for 12+. Patient observed for 15 min and physician discussed situation with the parent.
Numbness/tingling right side jaw pain, headache, cold sensation, facial puffiness, tightness in periorbital region.
Within 1-2 hrs of receiving vaccine the patient developed profuse diarrhea that lasted approx. 36 hrs. No vomiting, no respiratory and no skin reactions.